Drug intelligence / Profile preview

ologen

Development stage
Unknown
Lead developer
Aeon Astron
Modality
Hydrogel Systems → Drug Delivery Systems, Small Molecules
Administration
Surgical Implant, Ophthalmic
01

Overview

Ologen refers to two distinct products in ophthalmology: 1. **Ologen Collagen Matrix** is a biodegradable, porous collagen implant used as a wound healing modulator in glaucoma surgeries. It acts as a scaffold for fibroblast cells, promoting organized tissue regeneration and reducing postoperative scarring. The matrix is primarily composed of porcine-derived atelocollagen and is indicated as an adjunct in trabeculectomy, Ahmed glaucoma valve (AGV) implantation, Xen Gel Stent procedures, and bleb revisions to improve surgical outcomes by minimizing fibrosis. Clinical studies have shown that Ologen can achieve intraocular pressure (IOP) control comparable to mitomycin-C (MMC), with an excellent safety profile and reduced need for postoperative interventions[3][5][6]. 2. **Ologen DS** is also used as a brand name for olopatadine hydrochloride sterile eye drops (0.2%), which are antihistaminic medications indicated for the treatment of allergic conjunctivitis symptoms such as itching, redness, swelling, and watery eyes[1][4][7][8]. Olopatadine works by selectively antagonizing histamine H₁ receptors on conjunctival cells.

Brand names
ologenOlogen DS
Other names
Ologen Collagen Matrixologen collagen implant
02

Targets

HRH1 (Histamine H1 Receptor)

Beyond the preview

Go deeper on ologen.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ologen.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call